Early non-response to certolizumab pegol in rheumatoid arthritis predicts failure to achieve low disease activity at 1 year: data from a prospective observational study
暂无分享,去创建一个
F. Fagnani | A. Saraux | B. Combe | J. Massol | R. Flipo | G. Cukierman | J. Joubert | P. Huot-Marchand